The reasons why some patients with class 3 obesity develop complications and others do not require further clarification, not least because the development of complications may at least in part be genetically determined [such as through specific polymorphisms, e.g., in the fat mass and obesity-associated gene, FTO (30)] and therefore useful for personalized management. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.